These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2523612)

  • 1. Patients' choice of treatment in stage D prostate cancer.
    Cassileth BR; Soloway MS; Vogelzang NJ; Schellhammer PS; Seidmon EJ; Hait HI; Kennealey GT
    Urology; 1989 May; 33(5 Suppl):57-62. PubMed ID: 2523612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase III studies to compare goserelin (Zoladex) with orchiectomy and with diethylstilbestrol in treatment of prostatic carcinoma.
    Peeling WB
    Urology; 1989 May; 33(5 Suppl):45-52. PubMed ID: 2523611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zoladex: a sustained-release, monthly luteinizing hormone-releasing hormone analogue for the treatment of advanced prostate cancer.
    Ahmann FR; Citrin DL; deHaan HA; Guinan P; Jordan VC; Kreis W; Scott M; Trump DL
    J Clin Oncol; 1987 Jun; 5(6):912-7. PubMed ID: 2953870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of LHRH analogue (Zoladex) with orchiectomy in patients with metastatic prostatic carcinoma.
    Kaisary AV; Tyrrell CJ; Peeling WB; Griffiths K
    Br J Urol; 1991 May; 67(5):502-8. PubMed ID: 1828183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to orchiectomy following Zoladex therapy for metastatic prostate carcinoma.
    Silver RI; Straus FH; Vogelzang NJ; Kellman H; Chodak GW
    Urology; 1991 Jan; 37(1):17-21. PubMed ID: 1702566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zoladex versus orchiectomy in treatment of advanced prostate cancer: a randomized trial. Zoladex Prostate Study Group.
    Soloway MS; Chodak G; Vogelzang NJ; Block NL; Schellhammer PF; Smith JA; Scott M; Kennealey G; Gau TC
    Urology; 1991 Jan; 37(1):46-51. PubMed ID: 1824732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chemical castration using a depot LHRH-agonist as a palliative therapy concept in prostatic carcinoma--clinical, endocrinological and experimental studies].
    Kuber W; Treu T; Kratzik C; Girsch E; Zeillinger R; Spona J
    Wien Klin Wochenschr; 1990 Nov; 102(21):640-7. PubMed ID: 2148044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rat prostatic weight regression in reaction to ketoconazole, cyproterone acetate, and RU 23908 as adjuncts to a depot formulation of gonadotropin-releasing hormone analogue.
    Lamberts SW; Uitterlinden P; de Jong FH
    Cancer Res; 1988 Nov; 48(21):6063-8. PubMed ID: 2844399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long term therapy with a depot LHRH analogue (Zoladex) in patients with advanced prostatic cancer.
    Denis L; Keuppens F; Mahler C; Debruyne FM; Weil EH; Lunglmayr G; Newling D; Robinson MR; Richards B; Smith PH
    Prog Clin Biol Res; 1987; 243A():221-7. PubMed ID: 2958852
    [No Abstract]   [Full Text] [Related]  

  • 10. Quality of life and psychosocial status in stage D prostate cancer. Zoladex Prostate Cancer Study Group.
    Cassileth BR; Soloway MS; Vogelzang NJ; Chou JM; Schellhammer PD; Seidmon EJ; Kennealey GT
    Qual Life Res; 1992 Oct; 1(5):323-9. PubMed ID: 1299464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary hyperplasia after goserelin (LHRH-analogue) therapy.
    Radner H; Pummer K; Lax S; Wandschneider G; Höfler H
    Neuropathol Appl Neurobiol; 1991 Feb; 17(1):75-81. PubMed ID: 1647501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LHRH analogue as a depot preparation (Zoladex) in the treatment of advanced carcinoma of the prostate followed by orchiectomy as a second line therapy--a phase II study.
    Iversen P; Rose C; Stage JG; Iversen HG; Hansen RI; Hvidt V; Mogensen P; Pedersen T; Hansen JB
    Scand J Urol Nephrol; 1989; 23(3):177-83. PubMed ID: 2529629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison between surgical orchidectomy and LH-RH analogue ('Zoladex', ICI 118,630) in the treatment of advanced prostatic carcinoma--a multi-centre clinical study.
    Kaisary AV; Ryan PG; Turkes A; Peeling WB; Griffiths K
    Prog Clin Biol Res; 1988; 260():89-100. PubMed ID: 2966408
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of advanced prostatic carcinoma with a slow release depot LHRH analogue (Zoladex depot).
    Lukkarinen O; Kontturi M
    Scand J Urol Nephrol Suppl; 1988; 110():109-12. PubMed ID: 2973121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison between surgical orchidectomy and the LHRH agonist 'Zoladex' (ICI 188630) in the treatment of metastatic cancer of the prostate.
    Peeling WB
    Prog Clin Biol Res; 1989; 303():41-5. PubMed ID: 2528738
    [No Abstract]   [Full Text] [Related]  

  • 16. The patient's choice of androgen-deprivation therapy in locally advanced prostate cancer: bicalutamide, a gonadotrophin-releasing hormone analogue or orchidectomy.
    Nyman CR; Andersen JT; Lodding P; Sandin T; Varenhorst E
    BJU Int; 2005 Nov; 96(7):1014-8. PubMed ID: 16225519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary report on use of depot formulation of LHRH analogue ICI 118630 (Zoladex) in patients with prostatic cancer.
    Ahmed SR; Grant J; Shalet SM; Howell A; Chowdhury SD; Weatherson T; Blacklock NJ
    Br Med J (Clin Res Ed); 1985 Jan; 290(6463):185-7. PubMed ID: 3155636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Endocrine therapy for prostatic carcinoma--the clinical trial to compare the efficacy of LH-RH analogue, ICI 118630 (Zoladex) with castration or estrogen].
    Usami M; Kotake T; Matsuda M; Okajima E; Osafune M; Akaza H; Niijima T; Aso Y; Araki T; Itatani H
    Hinyokika Kiyo; 1988 Oct; 34(10):1853-63. PubMed ID: 2977527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term therapy with a depot luteinizing hormone-releasing hormone analogue (Zoladex) in patients with advanced prostatic carcinoma.
    Debruyne FM; Denis L; Lunglmayer G; Mahler C; Newling DW; Richards B; Robinson MR; Smith PH; Weil EH; Whelan P
    J Urol; 1988 Oct; 140(4):775-7. PubMed ID: 2971119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orchidectomy or LHRH-analogue? Which do the patients prefer and what treatment would Norwegian urologists prefer if they had advanced cancer of the prostate?
    Samdal F; Vada K; Lundmo PI; Mjølnerød OK
    Scand J Urol Nephrol; 1991; 25(3):197-9. PubMed ID: 1835129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.